Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 25% ± 6% | |
fibroblast | 7 studies | 19% ± 5% | |
glutamatergic neuron | 4 studies | 33% ± 12% | |
GABAergic neuron | 3 studies | 43% ± 0% | |
oligodendrocyte precursor cell | 3 studies | 29% ± 9% | |
adipocyte | 3 studies | 18% ± 2% | |
astrocyte | 3 studies | 23% ± 7% | |
oligodendrocyte | 3 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6130.28 | 1443 / 1445 | 100% | 27.43 | 183 / 183 |
prostate | 100% | 6524.03 | 244 / 245 | 100% | 48.03 | 502 / 502 |
brain | 99% | 3302.75 | 2608 / 2642 | 100% | 26.68 | 705 / 705 |
breast | 100% | 7262.51 | 459 / 459 | 99% | 32.79 | 1102 / 1118 |
lung | 100% | 5188.94 | 576 / 578 | 98% | 23.12 | 1137 / 1155 |
intestine | 99% | 6463.58 | 955 / 966 | 98% | 18.09 | 516 / 527 |
stomach | 100% | 6164.19 | 359 / 359 | 95% | 19.01 | 272 / 286 |
pancreas | 95% | 2557.60 | 311 / 328 | 99% | 19.69 | 176 / 178 |
bladder | 100% | 8233.62 | 21 / 21 | 93% | 15.11 | 469 / 504 |
liver | 100% | 4759.13 | 226 / 226 | 92% | 16.54 | 375 / 406 |
thymus | 100% | 4031.16 | 651 / 653 | 90% | 12.45 | 542 / 605 |
adrenal gland | 100% | 4939.68 | 258 / 258 | 88% | 15.73 | 203 / 230 |
uterus | 100% | 7636.23 | 170 / 170 | 88% | 14.56 | 403 / 459 |
skin | 100% | 7299.06 | 1808 / 1809 | 77% | 13.40 | 364 / 472 |
kidney | 80% | 1812.60 | 71 / 89 | 93% | 21.07 | 837 / 901 |
ovary | 100% | 4770.55 | 180 / 180 | 57% | 5.57 | 245 / 430 |
adipose | 100% | 8557.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10045.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 13429.09 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2961.60 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.56 | 1 / 1 |
heart | 99% | 5268.22 | 850 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 16.58 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 69% | 7.07 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 40% | 3.71 | 32 / 80 |
peripheral blood | 5% | 85.29 | 50 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0006974 | Biological process | DNA damage response |
GO_0045471 | Biological process | response to ethanol |
GO_0006338 | Biological process | chromatin remodeling |
GO_0018026 | Biological process | peptidyl-lysine monomethylation |
GO_0070828 | Biological process | heterochromatin organization |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0018027 | Biological process | peptidyl-lysine dimethylation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003682 | Molecular function | chromatin binding |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0140945 | Molecular function | histone H3K4 monomethyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SETD7 |
Protein name | Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.364) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9) SET domain containing 7, histone lysine methyltransferase |
Synonyms | SET7 SET9 KMT7 KIAA1717 |
Description | FUNCTION: Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3 . H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation . Plays a central role in the transcriptional activation of genes such as collagenase or insulin . Recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription . Has also methyltransferase activity toward non-histone proteins such as CGAS, p53/TP53, TAF10, and possibly TAF7 by recognizing and binding the [KR]-[STA]-K in substrate proteins . Monomethylates 'Lys-189' of TAF10, leading to increase the affinity of TAF10 for RNA polymerase II . Monomethylates 'Lys-372' of p53/TP53, stabilizing p53/TP53 and increasing p53/TP53-mediated transcriptional activation . Monomethylates 'Lys-491' of CGAS, promoting interaction between SGF29 and CGAS (By similarity). . |
Accessions | Q8WTS6 ENST00000506866.6 D6RJA0 ENST00000608795.5 B5MCZ8 ENST00000608958.1 ENST00000404104.7 ENST00000274031.8 V9GYG1 V9GY19 |